Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gds Regulatory News (SMSD)

Share Price Information for Samsung El.gds (SMSD)

Share Price is delayed by 15 minutes
Get Live Data
3,250.00    -280.00 (-7.93%)
Bid:
3,235.00
Ask:
3,245.00
Spread: 10.00 (0.309%)
Market Cap: $853.65b
SMSD Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gds Share Chart

  • This share is an international stock.

Single Sale and Supply Contract - Replacement

31 Jul 2025 08:55

RNS Number : 3724T
Samsung Electronics Co. Ld
31 July 2025
 

GENERAL TEXT AMENDMENT

 

The following amendment(s) has (have) been made to the 'Single Sale and Supply Contract' announcement released on 28/07/2025 at 09:19 under RNS No 7944S.

 

(DETAIL CHANGE).

Before

After

3. Contract counterparty

Large global company

Tesla, Inc.

9. Other important matters relevant to investment decisions

 

 

 

 

 

 

- In accordance with the counterparty's request to maintain business confidentiality, the contract name, counterparty, and key contract terms will be disclosed on the first business day following the withholding period.

- This is an update to the disclosure made on July 28, 2025, as the counterparty in the confidentiality protection request agreed to the disclosure of its identity.

 

- In accordance with the counterparty's request to maintain business confidentiality, the contract name and key contract terms will be disclosed on the first business day following the withholding period.

 

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

 

Single Sale and Supply Contract

 

1. Title of the contract

Supply agreement for semiconductor contract manufacturing

2. Contract details

Contract value

KRW 22,764,764,160,000

Annual revenue

(most recent fiscal year)

KRW 300,870,903,000,000

Contract-to-revenue ratio

7.6%

3. Contract counterparty

Tesla, Inc.

4. Sale region

-

5. Contract period

Start date

July 24, 2025

End date

December 31, 2033

6. Key contract terms

Existence of advance payment

None

Terms of payment, etc.

-

7. Contract date

July 26, 2025

8. Withholding of information

Reason for withholding

Confidentiality for business purposes

Withholding period

December 31, 2033

9. Other important matters relevant to investment decisions:

- This is an update to the disclosure made on July 28, 2025, as the counterparty in the confidentiality protection request agreed to the disclosure of its identity.

- The total contract amount in item 2 above in USD is approximately USD 16,544,160,000 based on the opening exchange rate on July 28, 2025 (i.e., 1,376.00 KRW/USD).

-The annual revenue in item 2 above is based on the consolidated financial statements as of end-2024.

- The above contract value, contract period, etc., may vary depending on operational circumstances.

- The start date in item 5 above refers to the effective date of contract as agreed upon by both parties, which differs from the contract date in the item 7.

- All dates stated in this document are based on Korea Standard Time (KST).

- In accordance with the counterparty's request to maintain business confidentiality, the contract name and key contract terms will be disclosed on the first business day following the withholding period.

- As the key details of the contract have not been disclosed to maintain business confidentiality, investors are advised to exercise caution, considering the possibility of changes to or termination of the contract.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFSDDTILVIE
12
Date   Source Headline
1st Jun 20268:51 amRNSCorporate Governance Report FY2025
29th May 20269:45 amRNS2026 1Q Interim Business Report
30th Apr 20269:03 amRNS2025 Business Report
30th Apr 20268:51 amRNSTransaction with Affiliate Company
30th Apr 20267:49 amRNSQuarterly Dividend for First Quarter 2026
30th Apr 20267:47 amRNS2026 1Q Earnings Release
24th Apr 20269:30 amRNSReport on Share Repurchase Results
7th Apr 20268:31 amRNSNotice of 1Q 2026 Earnings Release Schedule
7th Apr 20268:31 amRNS1Q 2026 Pre-Earnings Guidance
31st Mar 20268:32 amRNSDecision on Cancellation of Shares
25th Mar 20268:28 amRNSReport on Share Disposition Results
19th Mar 20267:46 amRNSSamsung Electronics Corporate Value Enhancement
18th Mar 20268:38 amRNSCharitable Contribution
18th Mar 20268:28 amRNSDecision on Share Disposition
18th Mar 20268:28 amRNSDecision on Share Repurchase
18th Mar 20268:28 amRNSResults of the 57th Annual General Meeting
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:47 amRNSReport on Share Repurchase Results
12th Mar 20267:47 amRNSReport on Share Repurchase Results
25th Feb 20267:00 amRNSReplacement of Reference Material for 2026 AGM
13th Feb 20267:44 amRNSCharitable Contributions
13th Feb 20267:43 amRNSReference Material for 2026 AMG
12th Feb 202610:04 amRNS2025 Consolidated Financial Statements
12th Feb 202610:03 amRNS2025 Separate Financial Statements
4th Feb 20268:50 amRNSReport on Share Disposition Results
29th Jan 20268:25 amRNSReport on Share Disposition Results
29th Jan 20268:24 amRNSDecision on Share Disposition
29th Jan 20268:23 amRNSDecision on Share Repurchase
29th Jan 20267:52 amRNS2025 Capex Results
29th Jan 20267:52 amRNSYear-End Dividend for FY2025
29th Jan 20267:00 amRNS2025 4Q Earnings Release
27th Jan 20268:20 amRNSReport on Share Repurchase Results
26th Jan 20267:00 amRNSDecision on Share Disposition
8th Jan 20268:23 amRNSNotice of 4Q 2025 Earnings Release Schedule
8th Jan 20268:23 amRNS4Q 2025 Pre-Earnings Guidance
7th Jan 202610:28 amRNSDecision on Share Repurchase
28th Nov 20258:32 amRNS2025 3Q Interim Business Report
28th Nov 20258:29 amRNSTransaction with Affiliate Company
28th Nov 20258:27 amRNSAppointment of New Chief Executive Officer
28th Nov 20258:27 amRNSCharitable Contribution
5th Nov 20258:19 amRNSReport on Share Disposition Results
30th Oct 20258:16 amRNSDecision on Share Disposition
30th Oct 20257:58 amRNSCharitable Contribution
30th Oct 20257:58 amRNSAnnouncement of Capex Plan for FY 2025
30th Oct 20257:56 amRNSQuarterly Dividend for Third Quarter 2025
30th Oct 20257:00 amRNS2025 3Q Earnings Release
14th Oct 20258:44 amRNSNotice of 3Q 2025 Earnings Release Schedule
14th Oct 20258:42 amRNS3Q 2025 Pre-Earnings Guidance
2nd Oct 20259:02 amRNSReport on Share Repurchase Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.